Literature DB >> 25168287

Beyond DNA repair: DNA-PK function in cancer.

Jonathan F Goodwin1, Karen E Knudsen2.   

Abstract

UNLABELLED: The DNA-dependent protein kinase (DNA-PK) is a pivotal component of the DNA repair machinery that governs the response to DNA damage, serving to maintain genome integrity. However, the DNA-PK kinase component was initially isolated with transcriptional complexes, and recent findings have illuminated the impact of DNA-PK-mediated transcriptional regulation on tumor progression and therapeutic response. DNA-PK expression has also been correlated with poor outcome in selected tumor types, further underscoring the importance of understanding its role in disease. Herein, the molecular and cellular consequences of DNA-PK are considered, with an eye toward discerning the rationale for therapeutic targeting of DNA-PK. SIGNIFICANCE: Although DNA-PK is classically considered a component of damage response, recent findings illuminate damage-independent functions of DNA-PK that affect multiple tumor-associated pathways and provide a rationale for the development of novel therapeutic strategies. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25168287      PMCID: PMC4184981          DOI: 10.1158/2159-8290.CD-14-0358

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  115 in total

Review 1.  Innate recognition of viruses.

Authors:  Andreas Pichlmair; Caetano Reis e Sousa
Journal:  Immunity       Date:  2007-09       Impact factor: 31.745

2.  EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment.

Authors:  Gianmaria Liccardi; John A Hartley; Daniel Hochhauser
Journal:  Cancer Res       Date:  2011-01-25       Impact factor: 12.701

Review 3.  Replication protein A: a heterotrimeric, single-stranded DNA-binding protein required for eukaryotic DNA metabolism.

Authors:  M S Wold
Journal:  Annu Rev Biochem       Date:  1997       Impact factor: 23.643

4.  DNAPKcs-dependent arrest of RNA polymerase II transcription in the presence of DNA breaks.

Authors:  Tibor Pankotai; Céline Bonhomme; David Chen; Evi Soutoglou
Journal:  Nat Struct Mol Biol       Date:  2012-02-12       Impact factor: 15.369

5.  Inhibition of homologous recombination by DNA-dependent protein kinase requires kinase activity, is titratable, and is modulated by autophosphorylation.

Authors:  Jessica A Neal; Van Dang; Pauline Douglas; Marc S Wold; Susan P Lees-Miller; Katheryn Meek
Journal:  Mol Cell Biol       Date:  2011-02-07       Impact factor: 4.272

Review 6.  DNA-PK: the means to justify the ends?

Authors:  Katheryn Meek; Van Dang; Susan P Lees-Miller
Journal:  Adv Immunol       Date:  2008       Impact factor: 3.543

7.  Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441.

Authors:  Yan Zhao; Huw D Thomas; Michael A Batey; Ian G Cowell; Caroline J Richardson; Roger J Griffin; A Hilary Calvert; David R Newell; Graeme C M Smith; Nicola J Curtin
Journal:  Cancer Res       Date:  2006-05-15       Impact factor: 12.701

8.  N-terminal constraint activates the catalytic subunit of the DNA-dependent protein kinase in the absence of DNA or Ku.

Authors:  Katheryn Meek; Susan P Lees-Miller; Mauro Modesti
Journal:  Nucleic Acids Res       Date:  2011-12-13       Impact factor: 16.971

Review 9.  Emerging common themes in regulation of PIKKs and PI3Ks.

Authors:  Harri Lempiäinen; Thanos D Halazonetis
Journal:  EMBO J       Date:  2009-09-24       Impact factor: 11.598

10.  Mutual regulation between DNA-PKcs and Snail1 leads to increased genomic instability and aggressive tumor characteristics.

Authors:  B-J Pyun; H R Seo; H-J Lee; Y B Jin; E-J Kim; N H Kim; H S Kim; H W Nam; J I Yook; Y-S Lee
Journal:  Cell Death Dis       Date:  2013-02-28       Impact factor: 8.469

View more
  88 in total

1.  Upregulation of the ALDOA/DNA-PK/p53 pathway by dietary restriction suppresses tumor growth.

Authors:  D Ma; X Chen; P-Y Zhang; H Zhang; L-J Wei; S Hu; J-Z Tang; M-T Zhou; C Xie; R Ou; Y Xu; K-F Tang
Journal:  Oncogene       Date:  2017-10-30       Impact factor: 9.867

2.  DNA-PKcs-Mediated Transcriptional Regulation Drives Prostate Cancer Progression and Metastasis.

Authors:  Jonathan F Goodwin; Vishal Kothari; Justin M Drake; Shuang Zhao; Emanuela Dylgjeri; Jeffry L Dean; Matthew J Schiewer; Christopher McNair; Jennifer K Jones; Alvaro Aytes; Michael S Magee; Adam E Snook; Ziqi Zhu; Robert B Den; Ruth C Birbe; Leonard G Gomella; Nicholas A Graham; Ajay A Vashisht; James A Wohlschlegel; Thomas G Graeber; R Jeffrey Karnes; Mandeep Takhar; Elai Davicioni; Scott A Tomlins; Cory Abate-Shen; Nima Sharifi; Owen N Witte; Felix Y Feng; Karen E Knudsen
Journal:  Cancer Cell       Date:  2015-07-13       Impact factor: 31.743

3.  Mitochondrial dysfunction and alcohol-associated liver disease: a novel pathway and therapeutic target.

Authors:  Mohamed A Abdallah; Ashwani K Singal
Journal:  Signal Transduct Target Ther       Date:  2020-03-03

Review 4.  Synthetic Lethality through the Lens of Medicinal Chemistry.

Authors:  Samuel H Myers; Jose Antonio Ortega; Andrea Cavalli
Journal:  J Med Chem       Date:  2020-11-02       Impact factor: 7.446

Review 5.  Targeting DNA Repair in Cancer: Beyond PARP Inhibitors.

Authors:  Jessica S Brown; Brent O'Carrigan; Stephen P Jackson; Timothy A Yap
Journal:  Cancer Discov       Date:  2016-12-21       Impact factor: 39.397

6.  Repair-independent functions of DNA-PKcs protect irradiated cells from mitotic slippage and accelerated senescence.

Authors:  Yue Liu; Elena V Efimova; Aishwarya Ramamurthy; Stephen J Kron
Journal:  J Cell Sci       Date:  2019-07-01       Impact factor: 5.285

Review 7.  Signaling Pathways as Potential Therapeutic Targets in Hepatocarcinogenesis.

Authors:  Yeliz Yılmaz; Ayşim Güneş; Hande Topel; Neşe Atabey
Journal:  J Gastrointest Cancer       Date:  2017-09

8.  Biphasic Functional Interaction between the Adenovirus E4orf4 Protein and DNA-PK.

Authors:  Keren Nebenzahl-Sharon; Hassan Shalata; Rakefet Sharf; Jana Amer; Hanan Khoury-Haddad; Sook-Young Sohn; Nabieh Ayoub; Patrick Hearing; Tamar Kleinberger
Journal:  J Virol       Date:  2019-05-01       Impact factor: 5.103

9.  Proteasome inhibitor bortezomib is a novel therapeutic agent for focal radiation-induced osteoporosis.

Authors:  Abhishek Chandra; Luqiang Wang; Tiffany Young; Leilei Zhong; Wei-Ju Tseng; Michael A Levine; Keith Cengel; X Sherry Liu; Yejia Zhang; Robert J Pignolo; Ling Qin
Journal:  FASEB J       Date:  2017-08-31       Impact factor: 5.191

10.  Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer.

Authors:  Naiyer A Rizvi; Matthew D Hellmann; Alexandra Snyder; Pia Kvistborg; Vladimir Makarov; Jonathan J Havel; William Lee; Jianda Yuan; Phillip Wong; Teresa S Ho; Martin L Miller; Natasha Rekhtman; Andre L Moreira; Fawzia Ibrahim; Cameron Bruggeman; Billel Gasmi; Roberta Zappasodi; Yuka Maeda; Chris Sander; Edward B Garon; Taha Merghoub; Jedd D Wolchok; Ton N Schumacher; Timothy A Chan
Journal:  Science       Date:  2015-03-12       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.